They are already experiencing age-related muscle loss (sarcopenia) at a rate of 1 to 2% per year, and adding semaglutide-induced weight loss on top accelerates the problem
Barrett A, Debackere N, Ribeiro A, Keapoletswe K, Zingel R, Coles B
These medications align directly with weight management needs and provide the right coverage and clinical backing for prospective candidates
Identifying crude drugs in Kampo medicines associated with drug-Induced liver injury using the Japanese adverse drug event report database: A comprehensive survey
[1] Symptoms include agitation, confusion, rapid heart rate, high temperature, and muscle twitching
Spezani and Mandarim-de-Lacerda, 2026